<SEC-DOCUMENT>0001193125-24-282050-index.html : 20241219
<SEC-HEADER>0001193125-24-282050.hdr.sgml : 20241219
<ACCEPTANCE-DATETIME>20241219163300
ACCESSION NUMBER:		0001193125-24-282050
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20241219
DATE AS OF CHANGE:		20241219
EFFECTIVENESS DATE:		20241219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Annexon, Inc.
		CENTRAL INDEX KEY:			0001528115
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				275414423
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283944
		FILM NUMBER:		241563805

	BUSINESS ADDRESS:	
		STREET 1:		1400 SIERRA POINT PARKWAY
		STREET 2:		BLDG C, SUITE 200
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		(650)-822-5500

	MAIL ADDRESS:	
		STREET 1:		1400 SIERRA POINT PARKWAY
		STREET 2:		BLDG C, SUITE 200
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d900991ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d900991ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d900991dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d900991dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d900991dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 3 - file: d900991dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d900991dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: d900991dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g900991dsp6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g900991dsp6.jpg

</DOCUMENT>
</SEC-DOCUMENT>